Septest Secures £1.1m to Advance Rapid Sepsis Diagnostic Tools

An estimated £1.1m has been raised by Septest Limited to support the development of infection-diagnostic tools, including the TRISEP multi-marker test. The investment values the Potters Bar-based business at approximately £4.5m. These tools are intended to give frontline clinicians fast, accurate information for the early detection of infection and sepsis.

The company was incorporated in 2022 and operates within the manufacture of medical and dental instruments and supplies sector. This technology is specifically designed for application in pre-hospital and community settings.

Financial records for the year ended 31 December 2024 show the firm maintained a headcount of one employee. This investment constitutes the total capital raised by the startup during 2026, with the share allotment completed in May.